Press Releases about Enanta Pharmaceutica
![](https://mms.businesswire.com/media/20220518006026/en/1460419/5/Enanta_RGB.jpg)
![](https://mms.businesswire.com/media/20220509005897/en/1448288/5/Enanta_RGB.jpg)
![](https://mms.businesswire.com/media/20220502005130/en/1438560/5/Enanta_RGB.jpg)
![](https://mms.businesswire.com/media/20220329005158/en/1402787/5/Enanta_RGB.jpg)
![](https://mms.businesswire.com/media/20220217005197/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20220216005144/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20220210005349/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20220208005331/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20220201005255/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20220106005094/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20220104005184/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20211122006607/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20211119005117/en/789698/5/enanta_logo-blue.jpg)
Enanta Pharmaceuticals to Participate in December Investor Conferences
November 19, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211118006197/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20211115006204/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20211112005340/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20211019005265/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20211006005607/en/789698/5/enanta_logo-blue.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20211005005361/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20211004005192/en/789698/5/enanta_logo-blue.jpg)
Enanta Pharmaceuticals Provides Update on NASH FXR Agonist Programs
October 04, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211001005120/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20210907005001/en/900425/5/4368511_enanta_logo-blue.jpg)
Enanta Pharmaceuticals to Participate in Investor Conferences in September
September 07, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210823005010/en/900466/4/Yujiro_Hata_HeadShot.jpg)
![](https://mms.businesswire.com/media/20210816005078/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20210805005808/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20210805005138/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20210729005136/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20210714005842/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20210622006097/en/789698/5/enanta_logo-blue.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.